Latest / Research To Practice | Oncology Videos
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Featuring an interview with Dr Laura Huppert, including the following topics:
General overview of antibody-drug conjugate (ADC) structure and function; mechanisms of resistance to ADCs (0:00)
Preventing and managing toxicities associated with trastuzumab deruxtecan (5:44)
Selecting between sacituzumab govitecan and datopotamab deruxtecan for patients with metastatic breast cancer; common toxicities associated with these 2 agents (9:30)
Potential use of ADCs in the first line for metastatic triple-negative breast cancer (mTNBC) (16:13)
Case: A woman in her mid 40s with mTNBC receives…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.